Free oral-head-and neck cancer screenings at May 25 Rome Braves game - Rome News Tribune
Free oral-head-and neck cancer screenings at May 25 Rome Braves game Rome News Tribune Tobacco use can cause cancer. The Braves, Northwest Georgia Public Health and the Northwest Georgia Regional Cancer Coalition will be conducting free oral-head-and-neck cancer screenings Friday, May 25, 7 pm, at State Mutual Stadium for attendees at ...
Late Stage Cancer Treatment Trends, Multiple Myeloma Vaccine, Predictors of ... - PR Web (press release)
Relay For Life reveals many faces of cancer - The Tennessean
Relay For Life reveals many faces of cancer The Tennessean Andrea Williams was diagnosed with cancer in 2010 and has undergone chemotherapy three times. / Sarah Kingsbury/Gallatin News Examiner Gallatin Fire Department Lt. Todd Wagoner, who has battled head and neck cancer for the past year, poses with Shift ...
Boehringer Ingelheim to present pivotal Phase III results for afatinib in ... - MarketWatch (press release)
Streatch cancer-free, ready to run for council again TheChronicleHerald.ca (STAFF / File) Following months of radiation and chemotherapy, Steve Streatch says he's now cancer-free and planning to run in October's municipal election. Doctors diagnosed the Eastern Shore-Musquodoboit Valley councillor with head and neck cancer in ...
Beastie Yauch's death puts rare salivary gland cancer in spotlight - Bend Bulletin
Beastie Yauch's death puts rare salivary gland cancer in spotlight Bend Bulletin Radiation, such as that used to treat head and neck cancer, can increase the risk of salivary gland cancer. Certain occupations, including rubber manufacturing, asbestos mining and plumbing, have been associated with higher rates.
First patient included in the phase II study of Amphinex® in head and neck ... - News-Medical.net
First patient included in the phase II study of Amphinex® in head and neck... News-Medical.net PCI Biotech (PCIB) the Norwegian biopharmaceutical company, reported today that the first patient has been included in the phase II study of Amphinex in combination with the cytotoxic agent bleomycin in head and neck cancer patients, called the ENHANCE ...
Advaxis Announces Cancer Research UK Initiates Phase 1/2 Clinical Trial of ... - MarketWatch (press release)
Study combines lapatinib with cetuximab to overcome resistance in EGFR-driven ... - EurekAlert (press release)
Study combines lapatinib with cetuximab to overcome resistance in EGFR-driven ... EurekAlert (press release) In cancers such as colon, head and neck, and lung, when cetuximab stops EGFR signaling, the machinery inside the cell doesn't get the signal to grow, in turn causing it to die. However, cancer cells can become resistant to cetuximab when the EGFR ...
What our clients and candidates are saying about us: Seriously, I couldn’t have asked for a better experience. I think there’s a number of individuals at my current employer who may be looking and I would definitely refer them to you! - E
The #1 Resource for professionals in the Pharmaceutical Advertising, Medical Communications, Healthcare Public Relations, Pharmaceutical Industry, and Biotechnology fields since 1988.